Emily Field
Stock Analyst at Barclays
(3.12)
# 2,629
Out of 4,703 analysts
848
Total ratings
46%
Success rate
2.1%
Average return
Main Sectors:
Stocks Rated by Emily Field
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Maintained: Buy | $1,400 | $1,149.36 | +21.81% | 28 | Aug 31, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | $110 | $72.72 | +51.27% | 9 | Aug 26, 2026 | |
| AMGN Amgen | Maintained: Hold | $360 → $380 | $437.23 | -13.09% | 8 | Aug 13, 2026 | |
| GILD Gilead Sciences | Maintained: Hold | $145 | $151.00 | -3.97% | 5 | Aug 13, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $150 | $150.33 | -0.22% | 12 | Aug 13, 2026 | |
| PFE Pfizer | Maintained: Sell | $25 | $28.45 | -12.13% | 6 | Aug 13, 2026 | |
| BIIB Biogen | Maintained: Hold | $200 | $220.83 | -9.43% | 7 | Aug 12, 2026 | |
| BMY Bristol-Myers Squibb Company | Reiterated: Buy | $75 | $66.82 | +12.24% | 8 | Aug 11, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $300 | $256.46 | +16.98% | 11 | Aug 11, 2026 | |
| GSK GSK plc | Downgraded: Sell | n/a | $49.89 | - | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $159.99 | - | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $44.24 | - | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $54.97 | - | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 275.00 | CHF 351.00 | -21.65% | 59 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 1,450p | 1,835p | n/a | 126 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €115.00 → €105.00 | €75.61 | n/a | 37 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 46.50 → CHF 55.00 | CHF 67.76 | n/a | 9 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | kr 700.00 → kr 375.00 | kr 303.71 | n/a | 54 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 14,000p | 12,086p | n/a | 78 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €22.00 | €24.24 | n/a | 32 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | CHF 90.00 | CHF 125.20 | n/a | 44 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €25.00 | €48.87 | n/a | 59 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 2,000p | 1,573p | n/a | 61 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | kr 2,100 | kr 2,165 | n/a | 45 | Apr 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €195.00 | €135.10 | n/a | 74 | Oct 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €390.00 → €430.00 | €885.60 | n/a | 21 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €8.00 → €9.00 | €9.81 | n/a | 4 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €75.00 | €163.85 | n/a | 22 | Nov 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €125.00 → €90.00 | €212.15 | n/a | 14 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $145 → $125 | $28.49 | n/a | 7 | Jan 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $53.27 | $22.44 | n/a | 1 | Aug 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $0.000001 | n/a | 1 | Apr 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $7.80 | n/a | 2 | Jun 1, 2018 |
Eli Lilly and Company
Aug 31, 2026
Maintained: Buy
Price Target: $1,400
Current: $1,149.36
Upside: +21.81%
Cytokinetics
Aug 26, 2026
Reiterated: Buy
Price Target: $110
Current: $72.72
Upside: +51.27%
Amgen
Aug 13, 2026
Maintained: Hold
Price Target: $360 → $380
Current: $437.23
Upside: -13.09%
Gilead Sciences
Aug 13, 2026
Maintained: Hold
Price Target: $145
Current: $151.00
Upside: -3.97%
Merck & Co.
Aug 13, 2026
Reiterated: Buy
Price Target: $150
Current: $150.33
Upside: -0.22%
Pfizer
Aug 13, 2026
Maintained: Sell
Price Target: $25
Current: $28.45
Upside: -12.13%
Biogen
Aug 12, 2026
Maintained: Hold
Price Target: $200
Current: $220.83
Upside: -9.43%
Bristol-Myers Squibb Company
Aug 11, 2026
Reiterated: Buy
Price Target: $75
Current: $66.82
Upside: +12.24%
AbbVie
Aug 11, 2026
Reiterated: Buy
Price Target: $300
Current: $256.46
Upside: +16.98%
GSK plc
Jan 6, 2026
Downgraded: Sell
Price Target: n/a
Current: $49.89
Upside: -
Jan 6, 2026
Upgraded: Hold
Price Target: n/a
Current: $159.99
Upside: -
Jan 6, 2026
Downgraded: Hold
Price Target: n/a
Current: $44.24
Upside: -
Jan 6, 2026
Upgraded: Buy
Price Target: n/a
Current: $54.97
Upside: -
Sep 24, 2025
Maintained: Hold
Price Target: CHF 275.00
Current: CHF 351.00
Upside: -21.65%
Aug 12, 2025
Maintained: Hold
Price Target: 1,450p
Current: 1,835p
Upside: n/a
Aug 12, 2025
Maintained: Buy
Price Target: €115.00 → €105.00
Current: €75.61
Upside: n/a
Aug 8, 2025
Maintained: Buy
Price Target: CHF 46.50 → CHF 55.00
Current: CHF 67.76
Upside: n/a
Aug 4, 2025
Maintained: Hold
Price Target: kr 700.00 → kr 375.00
Current: kr 303.71
Upside: n/a
Jul 30, 2025
Maintained: Buy
Price Target: 14,000p
Current: 12,086p
Upside: n/a
Jul 29, 2025
Maintained: Sell
Price Target: €22.00
Current: €24.24
Upside: n/a
Jul 21, 2025
Maintained: Sell
Price Target: CHF 90.00
Current: CHF 125.20
Upside: n/a
Jun 27, 2025
Maintained: Hold
Price Target: €25.00
Current: €48.87
Upside: n/a
Apr 25, 2025
Maintained: Hold
Price Target: 2,000p
Current: 1,573p
Upside: n/a
Apr 15, 2025
Maintained: Buy
Price Target: kr 2,100
Current: kr 2,165
Upside: n/a
Oct 29, 2024
Maintained: Buy
Price Target: €195.00
Current: €135.10
Upside: n/a
Jun 21, 2023
Maintained: Buy
Price Target: €390.00 → €430.00
Current: €885.60
Upside: n/a
Nov 21, 2022
Maintained: Sell
Price Target: €8.00 → €9.00
Current: €9.81
Upside: n/a
Nov 25, 2021
Maintained: Sell
Price Target: €75.00
Current: €163.85
Upside: n/a
Oct 15, 2021
Downgraded: Hold
Price Target: €125.00 → €90.00
Current: €212.15
Upside: n/a
Jan 19, 2021
Maintained: Hold
Price Target: $145 → $125
Current: $28.49
Upside: n/a
Aug 28, 2020
Maintained: Hold
Price Target: $53.27
Current: $22.44
Upside: n/a
Apr 25, 2019
Maintained: Buy
Price Target: $14
Current: $0.000001
Upside: n/a
Jun 1, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $7.80
Upside: n/a